Published in J Interv Card Electrophysiol on February 25, 2015
Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation. Eur Heart J (2004) 4.71
Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol (2005) 4.40
Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation: a randomized controlled study. J Am Coll Cardiol (2012) 3.02
Indications for the use of diagnostic implantable and external ECG loop recorders. Europace (2009) 2.06
Intracardiac and extracardiac markers of inflammation during atrial fibrillation. Heart Rhythm (2009) 2.00
Mipomersen, an apolipoprotein B synthesis inhibitor, lowers low-density lipoprotein cholesterol in high-risk statin-intolerant patients: a randomized, double-blind, placebo-controlled trial. Eur Heart J (2012) 1.79
Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials. J Am Coll Cardiol (2008) 1.66
A preliminary assessment of the effects of ATI-2042 in subjects with paroxysmal atrial fibrillation using implanted pacemaker methodology. Europace (2009) 1.43
Effects of CRP infusion on endothelial function and coagulation in normocholesterolemic and hypercholesterolemic subjects. J Lipid Res (2007) 1.11
The efficacy and dosage effect of corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a systematic review. J Crit Care (2009) 1.06
2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures. J Thorac Cardiovasc Surg (2014) 0.99
High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial. Eur Heart J (2011) 0.99
A Selective Inhibitor of Human C-reactive Protein Translation Is Efficacious In Vitro and in C-reactive Protein Transgenic Mice and Humans. Mol Ther Nucleic Acids (2012) 0.97
High-sensitivity C-reactive protein as a predictor of atrial fibrillation recurrence after primary circumferential pulmonary vein isolation. Pacing Clin Electrophysiol (2010) 0.91
Inhibition of coagulation by a phosphorothioate oligonucleotide. Antisense Nucleic Acid Drug Dev (1997) 0.87
Effects of an antisense oligonucleotide inhibitor of C-reactive protein synthesis on the endotoxin challenge response in healthy human male volunteers. J Am Heart Assoc (2014) 0.77
Inflammatory activation in an unselected population of subjects with atrial fibrillation: links with structural heart disease, atrial remodeling and recent onset. Intern Emerg Med (2011) 0.75
The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med (2005) 20.72
Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Arch Gen Psychiatry (2006) 4.30
The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J (2006) 4.10
Putting the record straight on aprotinin as safe and effective: results from a mixed treatment meta-analysis of trials of aprotinin. J Thorac Cardiovasc Surg (2012) 3.74
Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J (2006) 3.55
Impact of NICE guidance on laparoscopic surgery for inguinal hernias: analysis of interrupted time series. BMJ (2003) 3.39
Clinical medication review by a pharmacist of elderly people living in care homes--randomised controlled trial. Age Ageing (2006) 3.21
Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework. PLoS One (2013) 2.50
Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses. J Am Coll Cardiol (2011) 2.42
Evaluation of a complex intervention for changing professional behaviour: the Evidence Based Out Reach (EBOR) Trial. J Health Serv Res Policy (2002) 2.33
Effect of the quality and outcomes framework on diabetes care in the United Kingdom: retrospective cohort study. BMJ (2009) 2.25
Medicalisation, limits to medicine, or never enough money to go around? BMJ (2002) 2.21
Specialist nurse-led intervention to treat and control hypertension and hyperlipidemia in diabetes (SPLINT): a randomized controlled trial. Diabetes Care (2003) 2.19
Response rate or time to progression as predictors of survival in trials of metastatic colorectal cancer or non-small-cell lung cancer: a meta-analysis. Lancet Oncol (2006) 2.17
Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis. Br J Psychiatry (2002) 2.17
Bleeding in cardiac surgery: the use of aprotinin does not affect survival. J Thorac Cardiovasc Surg (2008) 2.15
Catheter ablation of recurrent scar-related ventricular tachycardia using electroanatomical mapping and irrigated ablation technology: results of the prospective multicenter Euro-VT-study. J Cardiovasc Electrophysiol (2009) 2.14
Gender and variation in activity rates of hospital consultants. J R Soc Med (2008) 2.08
Indications for the use of diagnostic implantable and external ECG loop recorders. Europace (2009) 2.06
Targeting APOC3 in the familial chylomicronemia syndrome. N Engl J Med (2014) 2.06
Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia. N Engl J Med (2015) 2.03
Reply to the editor. J Thorac Cardiovasc Surg (2013) 1.97
Challenges for the National Institute for Clinical Excellence. BMJ (2004) 1.93
Cluster randomised controlled trial of the effectiveness of primary care mental health workers. Br J Gen Pract (2007) 1.91
Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial. Eur Heart J (2005) 1.81
Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: a pre-defined analysis from the CARE-HF trial. Eur Heart J (2007) 1.81
Variation in recorded child maltreatment concerns in UK primary care records: a cohort study using The Health Improvement Network (THIN) database. PLoS One (2012) 1.80
Examination performance of graduate entry medical students compared with mainstream students. J R Soc Med (2009) 1.72
Do men consult less than women? An analysis of routinely collected UK general practice data. BMJ Open (2013) 1.69
The impact of chronic heart failure on health-related quality of life data acquired in the baseline phase of the CARE-HF study. Eur J Heart Fail (2005) 1.68
The limit of plausibility for predictors of response: application to biventricular pacing. JACC Cardiovasc Imaging (2012) 1.67
Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony. Eur Heart J (2007) 1.65
Variation in activity rates of consultant surgeons and the influence of reward structures in the English NHS. J Health Serv Res Policy (2004) 1.63
The Heart Failure Revascularisation Trial (HEART). Eur J Heart Fail (2010) 1.57
Are randomized trials conducted in China or India biased? A comparative empirical analysis. J Clin Epidemiol (2010) 1.55
The new EuroSCORE II does not improve prediction of mortality in high-risk patients undergoing cardiac surgery: a collaborative analysis of two European centres. Eur J Cardiothorac Surg (2013) 1.55
Meta-analysis of brain weight in schizophrenia. Schizophr Res (2003) 1.54
Antenatal peer support workers and initiation of breast feeding: cluster randomised controlled trial. BMJ (2009) 1.48
Do shock absorbing insoles in recruits undertaking high levels of physical activity reduce lower limb injury? A randomized controlled trial. J R Soc Med (2006) 1.48
A preliminary assessment of the effects of ATI-2042 in subjects with paroxysmal atrial fibrillation using implanted pacemaker methodology. Europace (2009) 1.43
The relationship between high-frequency right ventricular pacing and paroxysmal atrial fibrillation burden. Europace (2009) 1.43
Commentary on the EBOR trial report. Br J Gen Pract (2002) 1.40
Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE. Eur J Heart Fail (2006) 1.38
Psychosocial aspects of patient-activated atrial defibrillation. J Cardiovasc Electrophysiol (2003) 1.37
The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator. Eur Heart J (2006) 1.36
An assessment of the quality of randomised controlled trials conducted in China. Trials (2008) 1.35
Long-term left ventricular reverse remodelling with cardiac resynchronization therapy: results from the CARE-HF trial. Eur J Heart Fail (2009) 1.32
Trap of trends to statistical significance: likelihood of near significant P value becoming more significant with extra data. BMJ (2014) 1.26
Management of type 2 diabetes with multiple oral hypoglycaemic agents or insulin in primary care: retrospective cohort study. Br J Gen Pract (2007) 1.25
Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure. Eur J Heart Fail (2004) 1.24
The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis. Eur Arch Psychiatry Clin Neurosci (2009) 1.23
The clinical impact of implantable loop recorders in patients with syncope. Eur Heart J (2005) 1.22
Long-term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) trial. Eur J Heart Fail (2012) 1.19
The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis. Eur J Heart Fail (2002) 1.17
Effects of cardiac resynchronization therapy on long-term quality of life: an analysis from the CArdiac Resynchronisation-Heart Failure (CARE-HF) study. Am Heart J (2009) 1.16
Evaluation of the management of heart failure in primary care. Fam Pract (2009) 1.15
Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub-analysis of the CARE-HF trial. Eur J Heart Fail (2009) 1.14
Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial. J Am Coll Cardiol (2008) 1.14
Physiotherapy rehabilitation post first lumbar discectomy: a systematic review and meta-analysis of randomized controlled trials. Spine (Phila Pa 1976) (2011) 1.14
Relation between mild renal dysfunction and outcomes after coronary artery bypass grafting. Circulation (2005) 1.13
Updating evidence-based clinical guidelines. J Health Serv Res Policy (2002) 1.13
REDIRECT: cluster randomised controlled trial of GP training in first-episode psychosis. Br J Gen Pract (2009) 1.12
Reducing duration of untreated psychosis: care pathways to early intervention in psychosis services. Br J Psychiatry (2013) 1.11
A systematic review of risk prediction in adult cardiac surgery: considerations for future model development. Eur J Cardiothorac Surg (2013) 1.06
Patients' perceptions of subcutaneous insulin in the OPTIMIZE study: a multicenter follow-up study. Diabetes Technol Ther (2008) 1.06
Prevalence of heart failure and atrial fibrillation in minority ethnic subjects: the Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES). PLoS One (2011) 1.05
Systematic review of peer support for breastfeeding continuation: metaregression analysis of the effect of setting, intensity, and timing. BMJ (2012) 1.04
Cost-effective undergraduate medical education? J R Soc Med (2009) 1.04
Relationship of indices of inflammation and thrombogenesis to arrhythmia burden in paroxysmal atrial fibrillation. Chest (2009) 1.04
Specialist nurse-led clinics to improve control of hypertension and hyperlipidemia in diabetes: economic analysis of the SPLINT trial. Diabetes Care (2005) 1.03
The unmet need for interpreting provision in UK primary care. PLoS One (2011) 1.03
The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial. Eur Heart J (2009) 1.02
Trends in consultant clinical activity and the effect of the 2003 contract change: retrospective analysis of secondary data. J R Soc Med (2012) 1.01
Access to interpreting services in England: secondary analysis of national data. BMC Public Health (2009) 1.00
Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure. Circulation (2006) 0.99
Composite and surrogate outcomes in randomised controlled trials. BMJ (2007) 0.97
The use of interim data and Data Monitoring Committee recommendations in randomized controlled trial reports: frequency, implications and potential sources of bias. BMC Med Res Methodol (2008) 0.96
Prevalence of ECG abnormalities in an international survey of patients with suspected or confirmed heart failure at death or discharge. Eur J Heart Fail (2007) 0.96
Development and validation of the Economic Assessment of Glycemic Control and Long-Term Effects of diabetes (EAGLE) model. Diabetes Technol Ther (2006) 0.95
The UK national evaluation of the development and impact of Early Intervention Services (the National EDEN studies): study rationale, design and baseline characteristics. Early Interv Psychiatry (2013) 0.94
Cardiac resynchronization therapy: are modern myths preventing appropriate use? J Am Coll Cardiol (2009) 0.93
A randomised controlled non-inferiority trial of primary care-based facilitated access to an alcohol reduction website (EFAR-FVG): the study protocol. BMJ Open (2013) 0.92
Observational evidence for determining drug safety. BMJ (2008) 0.92
What drives health-care spending priorities? An international survey of health-care professionals. PLoS Med (2007) 0.92
New insights into the initiation of atrial fibrillation: a detailed intraindividual and interindividual analysis of the spontaneous onset of atrial fibrillation using new diagnostic pacemaker features. Circulation (2006) 0.91
Design of the BiRmingham Early Detection In untREated psyChosis Trial (REDIRECT): cluster randomised controlled trial of general practitioner education in detection of first episode psychosis [ISRCTN87898421]. BMC Health Serv Res (2005) 0.91
Predictors of mortality from pump failure and sudden cardiac death in patients with systolic heart failure and left ventricular dyssynchrony: results of the CARE-HF trial. J Card Fail (2008) 0.91
Effect of cardiac resynchronization on morbidity and mortality of diabetic patients with severe heart failure. Diabetes Care (2007) 0.89
Baseline observations from the POSSIBLE EU® study: characteristics of postmenopausal women receiving bone loss medications. Arch Osteoporos (2010) 0.89
The diagnosis of heart failure in European primary care: The IMPROVEMENT Programme survey of perception and practice. Eur J Heart Fail (2005) 0.88
How do we diagnose syncope? J Cardiovasc Electrophysiol (2002) 0.88
Long-term cost-effectiveness analysis of nebivolol compared with standard care in elderly patients with heart failure: an individual patient-based simulation model. Pharmacoeconomics (2008) 0.88
Protocol for Past BP: a randomised controlled trial of different blood pressure targets for people with a history of stroke of transient ischaemic attack (TIA) in primary care. BMC Cardiovasc Disord (2010) 0.88
Rationale and study design of a cross sectional study documenting the prevalence of Heart Failure amongst the minority ethnic communities in the UK: the E-ECHOES Study (Ethnic--Echocardiographic Heart of England Screening Study). BMC Cardiovasc Disord (2009) 0.87
Use of primary care data for detecting impetigo trends, United kingdom, 1995-2010. Emerg Infect Dis (2013) 0.87
Relation of sex, age and concomitant diseases to drug prescription for heart failure in primary care in Europe. Eur J Heart Fail (2004) 0.87
Designing an intervention to help people with colorectal adenomas reduce their intake of red and processed meat and increase their levels of physical activity: a qualitative study. BMC Cancer (2012) 0.87